Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M302105200 on April 3, 2003

J. Biol. Chem., Vol. 278, Issue 25, 23008-23019, June 20, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/25/23008    most recent
M302105200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, X.-Y.
Right arrow Articles by Lengyel, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, X.-Y.
Right arrow Articles by Lengyel, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Interferon-inducible p202a Protein Modulates NF-{kappa}B Activity by Inhibiting the Binding to DNA of p50/p65 Heterodimers and p65 Homodimers While Enhancing the Binding of p50 Homodimers*

Xian-Yong Ma {ddagger} §, Hong Wang {ddagger} ¶, Bo Ding {ddagger}, Haihong Zhong || **, Sankar Ghosh || and Peter Lengyel {ddagger} {ddagger}{ddagger}

From the {ddagger}Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06520 and the ||Immunobiology Section and Howard Hughes Medical Institute, Yale University, New Haven, Connecticut 06520

p202a is a member of the interferon-inducible murine p200 family of proteins. These proteins share 1 or 2 partially conserved 200 amino acid segments of the a or the b type. The known biological activities of p202a include among others the regulation of muscle differentiation, cell proliferation, and apoptosis. These biological activities of p202a can be correlated with the inhibition of the activity of several transcription factors. Thus, the binding of p202a results in the inhibition of the sequence-specific binding to DNA of the c-Fos, c-Jun, E2F1, E2F4, MyoD, myogenin, and c-Myc transcription factors. This study concerns the mechanisms by which p202a inhibits the activity of NF-{kappa}B, a transcription factor involved among others in host defense, inflammation, immunity, and the apoptotic response. NF-{kappa}B consists of p50 and p65 subunits. We demonstrate that p202a can inhibit in vitro and in vivo the binding to DNA of p65 homodimers and p50/65 heterodimers, whereas it increases the binding of p50 homodimers. Thus p202a can impair NF-{kappa}B activity both by inhibiting the binding to DNA of the transcriptionally active p65 homodimers and p50/p65 heterodimers and by boosting the binding of the repressive p50 homodimers. p202a can bind p50 and p65 in vitro and in vivo, and p202a can be part of the p50 homodimer complex bound to DNA. p50 binds in p202a to the a type segment, whereas p65 binds to the b type segment. Transfected ectopic p202a increases the apoptotic effect of tumor necrosis factor (at least in part) by inhibiting NF-{kappa}B and its antiapoptotic activity.


Received for publication, February 27, 2003

* This work was supported by postdoctoral fellowships from the Cancer Research Institute (to H. W.) and the Leukemia Society of America (to H. Z.). Support was also obtained from the Howard Hughes Medical Institute (to S. G.) and research grants from the National Institutes of Health (to S. G. and P. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Dept. of Laboratory Medicine, Yale University, New Haven, CT 06520.

Present address: Dept. of Surgery, Northshore University Hospital, Northshore LIJ Research Institute, Manhasset, NY 11030.

** Present address: Curagen Corp., Branford, CT 06405.

{ddagger}{ddagger} To whom correspondence should be addressed: Dept. of Molecular Biophysics and Biochemistry, Yale University, 333 Cedar St., New Haven, CT 06520. Tel.: 203-737-2061; Fax: 203-785-7979; E-mail: peter.lengyel{at}yale.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Ding and P. Lengyel
p204 Protein Is a Novel Modulator of Ras Activity
J. Biol. Chem., February 29, 2008; 283(9): 5831 - 5848.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Yamauchi, M. Hashimoto, K. Ichiyama, R. Yoshida, T. Hanada, T. Muta, S. Komune, T. Kobayashi, and A. Yoshimura
Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-{kappa}B activation in dendritic cells
Int. Immunol., August 16, 2007; (2007) dxm054v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Ding, C.-j. Liu, Y. Huang, R. P. Hickey, J. Yu, W. Kong, and P. Lengyel
p204 Is Required for the Differentiation of P19 Murine Embryonal Carcinoma Cells to Beating Cardiac Myocytes: ITS EXPRESSION IS ACTIVATED BY THE CARDIAC GATA4, NKX2.5, AND TBX5 PROTEINS
J. Biol. Chem., May 26, 2006; 281(21): 14882 - 14892.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Ding, C.-j. Liu, Y. Huang, J. Yu, W. Kong, and P. Lengyel
p204 Protein Overcomes the Inhibition of the Differentiation of P19 Murine Embryonal Carcinoma Cells to Beating Cardiac Myocytes by Id Proteins
J. Biol. Chem., May 26, 2006; 281(21): 14893 - 14906.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. F. Liu and A. B. Malik
NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L622 - L645.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
I-F. Chen, F. Ou-Yang, J.-Y. Hung, J.-C. Liu, H. Wang, S.-C. Wang, M.-F. Hou, G. N. Hortobagyi, and M.-C. Hung
AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model
Mol. Cancer Ther., January 1, 2006; 5(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. F. Gomez, M. H. Pillinger, M. Attur, N. Marjanovic, M. Dave, J. Park, C. O. Bingham III, H. Al-Mussawir, and S. B. Abramson
Resolution of Inflammation: Prostaglandin E2 Dissociates Nuclear Trafficking of Individual NF-{kappa}B Subunits (p65, p50) in Stimulated Rheumatoid Synovial Fibroblasts
J. Immunol., November 15, 2005; 175(10): 6924 - 6930.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement